Akèy › Ensifizyans kadyak › North Carolina › Wilmington

Etid klinik pou Ensifizyans kadyak nan Wilmington, NC

6 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Wilmington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Ap rekriteFaz 3

Research Site, Wilmington

Laj 18 a 130 · Tout sèks · Mizajou Oct 2, 2026 · NCT06307652

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Ap rekriteFaz 3

Wilmington Health, Wilmington

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06935370

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Ap rekriteFaz 3

Research Site, Wilmington

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3

Accellacare of Wilmington, Wilmington

Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3

Research Site, Wilmington

Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3

Accellacare Wilmington, Wilmington

Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Wilmington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.